Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial.
CONCLUSIONS: Despite insulin resistance remaining unchanged we show, to our knowledge, the first sustained improvements in vascular function, lipid status, and underlying NO bioactivity following 1 cup blueberries/d. With effect sizes predictive of 12-15% reductions in CVD risk, blueberries should be included in dietary strategies to reduce individual and population CVD risk. This study was registered at clinicaltrials.gov as NCT02035592.
PMID: 31136659 [PubMed - in process]
Source: The American Journal of Clinical Nutrition - Category: Nutrition Authors: Curtis PJ, van der Velpen V, Berends L, Jennings A, Feelisch M, Umpleby AM, Evans M, Fernandez BO, Meiss MS, Minnion M, Potter J, Minihane AM, Kay CD, Rimm EB, Cassidy A Tags: Am J Clin Nutr Source Type: research
More News: Academia | Blueberries | Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Type 2 | Diets | Endocrinology | Heart | Insulin | Metabolic Syndrome | Nutrition | Statin Therapy | Study